Accessibility Menu

Curative Biotechnology(OTC) CTYX

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)-100%
5 Year-95%
1 Year-33%
1 Month-25%
N/A
Curative Biotechnology last closing stock price
MetricPriceDate
Last closeUSD 0.902026-08-28
Curative Biotechnology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-10%USD 1.002026-08-21
1 month-25%USD 1.202026-07-29
3 month-44.1%USD 1.612026-05-29
Year to date+11.11%USD 0.812025-12-31
1 year-32.74%USD 1.342025-08-28
3 year-62.5%USD 2.402023-08-29
5 year-94.55%USD 16.502021-08-27
Since inception-99.99%USD 7,499.962008-02-22

Curative Biotechnology Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$2.03

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

N/A

CTYX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Curative Biotechnology

Curative Biotechnology, Inc. engages in the provision of software solutions for the healthcare market. Its products include MedFlash, electronic Personal Health Manager, Medical Alert, personal emergency response services, product and medical transcription, disease management, revenue cycle management, and medical consulting-billing. The company was founded by Jon Pevzner on July 29, 1995 and is headquartered in Boca Raton, FL.

Industry

Biotechnology

Sector

Health Care

Employees

3

CEO

I. Richard Garr

Website

www.curativebiotech.com

CTYX Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

N/A

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Curative Biotechnology Performance Analysis

Curative Biotechnology annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Curative Biotechnology annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.43-74.5%
20232023-12-31USD -1.32-8.1%
20242024-12-31USD -0.58-55.9%
20252025-12-31USD -0.44-23.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$0.02

+1.0%

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.03

N/A

Employees

3

N/A

Net Income

-$0.61

+0.9%

EBITDA

-$0.35

+0.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$1.50

+5.9%

Total Debt

$1.36

+1.0%

Accounts Receivable

N/A

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$1.36

+1.0%

Return on Assets

-95.02%

+0.7%

Return on Invested Capital

25.60%

-0.7%

Free Cash Flow

-$0.34

+1.8%

Operating Cash Flow

-$0.34

+1.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.29-0.07%
NVDANvidia
$217.44-0.02%
INTCIntel
$88.48-0.01%
NUNu Holdings
$14.48-0.01%

Questions About CTYX

What is the current price of Curative Biotechnology?

Curative Biotechnology is trading at N/A per share.

What is the 52-week range for Curative Biotechnology?

Over the past 52 weeks, Curative Biotechnology has traded between N/A and N/A.

How much debt does Curative Biotechnology have?

As of the most recent reporting period, Curative Biotechnology reported total debt of $1.36M.

How much cash does Curative Biotechnology have on hand?

Curative Biotechnology reported $145.26K in cash and cash equivalents in its most recent financial results.

What is Curative Biotechnology’s dividend yield?

Curative Biotechnology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services